MedPath

Prophylactic pectoralis major flap to compensate for increased risk of pharyngocutaneous fistula in laryngectomy patients with low skeletal muscle mass

Conditions
Patients who are planned for TL (advanced stage primary laryngeal or hypopharyngeal cancer, salvage patients with recurrent disease after failure of initial organ preserving treatment, dysfunctional larynx)
Registration Number
NL-OMON26043
Lead Sponsor
MC Utrecht
Brief Summary

.A.

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
276
Inclusion Criteria

Planned for TL.
- Eighteen years of age or older, and able to exercise their free will.
- Sufficient understanding of the Dutch language to give informed consent.

Exclusion Criteria

- Planned for TL with PMMC for reconstruction of the pharynx.
- Major CT or MRI artefacts, impeding accurate muscle tissue identification on CT imaging.
- Interval between TL and imaging > 2 months.
- Concurrent treatment with chemotherapy for a previously diagnosed head and neck carcinoma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome of this randomized clinical trial is the PCF rate following TL in patients with low SMM with or without PMMF as onlay for reinforcement.
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes of this study are hospital stay, shoulder- and neck function, swallowing function, voice quality, quality of life, patients’ perspective, and costs.
© Copyright 2025. All Rights Reserved by MedPath